These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial. Fallahzadeh MK; Dormanesh B; Sagheb MM; Roozbeh J; Vessal G; Pakfetrat M; Daneshbod Y; Kamali-Sarvestani E; Lankarani KB Am J Kidney Dis; 2012 Dec; 60(6):896-903. PubMed ID: 22770926 [TBL] [Abstract][Full Text] [Related]
3. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy. Berglund J Acta Med Scand Suppl; 1988; 722():1-69. PubMed ID: 3163465 [TBL] [Abstract][Full Text] [Related]
6. [Diabetic nephropathy--recent therapeutic concepts]. Schmidt P Wien Klin Wochenschr; 1990 Mar; 102(5):121-5. PubMed ID: 2181781 [TBL] [Abstract][Full Text] [Related]
7. Diabetic nephropathy. Ritz E Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681 [TBL] [Abstract][Full Text] [Related]
8. [Early detection and control of risk factors in diabetic nephropathy]. Fernández López MT; Isidro San Juan ML; Cordido F An Med Interna; 1998 Nov; 15(11):600-5. PubMed ID: 9882860 [TBL] [Abstract][Full Text] [Related]
9. [Risk and prevention of diabetic nephropathy]. Ravera M; Re M; Deferrari G G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442 [TBL] [Abstract][Full Text] [Related]
10. [Diabetic nephropathy--screening, follow-up and treatment. Nephropathy Study Groups of The Finnish Diabetes Organization]. Koivisto V; Groop PH; Huttunen NP; Kivekäs J; Pasternack A; Uusitupa M; Viikari J Nord Med; 1997 May; 112(5):154-62. PubMed ID: 9273505 [TBL] [Abstract][Full Text] [Related]
11. Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring. Rossing K Dan Med Bull; 2007 May; 54(2):79-98. PubMed ID: 17521525 [No Abstract] [Full Text] [Related]
13. Diabetic nephropathy: early detection, prevention and management. Maher JF Am Fam Physician; 1992 Apr; 45(4):1661-8. PubMed ID: 1558042 [TBL] [Abstract][Full Text] [Related]
14. Treatment of diabetic nephropathy in its early stages. Deferrari G; Ravera M; Berruti V Diabetes Metab Res Rev; 2003; 19(2):101-14. PubMed ID: 12673778 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and management of diabetic nephropathy]. Kitada M; Koya D Nihon Rinsho; 2015 Dec; 73(12):2037-43. PubMed ID: 26666150 [TBL] [Abstract][Full Text] [Related]
16. Twelve shifting paradigms in diabetic renal disease and hypertension. Mogensen CE Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897 [TBL] [Abstract][Full Text] [Related]
17. Prognosis and treatment of diabetic nephropathy: Recent advances and perspectives. Rossing P; Persson F; Frimodt-Møller M Nephrol Ther; 2018 Apr; 14 Suppl 1():S31-S37. PubMed ID: 29606261 [TBL] [Abstract][Full Text] [Related]
18. Management of early nephropathy in diabetic patients. Mogensen CE Annu Rev Med; 1995; 46():79-93. PubMed ID: 7598486 [TBL] [Abstract][Full Text] [Related]
19. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Steinke JM; Mauer M; Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710 [TBL] [Abstract][Full Text] [Related]
20. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study. Barnett AH Acta Diabetol; 2005 Apr; 42 Suppl 1():S42-9. PubMed ID: 15868119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]